Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference

Goodship, T.H.J.; Cook, H.T.; Fakhouri, F.; Fervenza, F.C.; Fremeaux-Bacchi, V.; Kavanagh, D.; ... ; Conf Participants (2017)

Article / Letter to editor

• anti-complement therapies
• atypical hemolytic uremic syndrome
• C3 glomerulopathy
• complement
• glomerulonephritis
• kidney disease

• All authors: Goodship, T.H.J.; Cook, H.T.; Fakhouri, F.; Fervenza, F.C.; Fremeaux-Bacchi, V.; Kavanagh, D.; Nester, C.M.; Noris, M.; Pickering, M.C.; Cordoba, S.R. de; Roumenina, L.T.; Sethi, S.; Smith, R.J.H.; Conf Participants
• Date: 2017-03-31
• Journal: Kidney International
• Volume: 91
• Issue: 3
• Pages: 539 - 551
• DOI: doi:10.1016/j.kint.2016.10.005